Riskpilot← Back to searchSign inGet full accessCapio SkinDoc AB
ABActiveOrg 5568574080SollentunaMedical specialists activities · NACE 8622Est. 201123 employees
Revenue 2025
SEK 67,2M
+9% vs 2024
EBITDA margin
12.5%
+21% vs 2024
Equity ratio
73.3%
Financial strength
Net profit 2025
SEK 0
-100% vs 2024
| Revenue | SEK 67,2M | +9% |
| EBITDA | SEK 8,4M | +21% |
| Net profit | SEK 0 | -100% |
| Total assets | SEK 62,5M | -3% |
| Equity | SEK 45,8M | +0% |
| Employees | 23 | — |
Legal name
Capio SkinDoc AB
Org number
5568574080
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
29 juni 2011
Share capital
SEK 50 000
Employees
23 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas av en av ledamöterna i förening med externa firmatecknaren Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget är vårdgivare som i samarbete med andra vårdgivare ska bedriva verksamhet inom specialiserad hälso- och sjukvård, samt därmed förenlig verksamhet.
Address
Sollentuna
Email
eksupport.sthlm@capio.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 54 181 | 53 660 | 55 603 | 76 606 | 57 672 | 62 250 | 61 392 | 67 211 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 2 426 | 2 747 | 3 240 | 5 334 | 4 468 | 25 228 | 11 906 | 11 307 | 6 939 | 8 373 |
| Depreciation & amort. | −64 | −50 | −34 | −23 | −23 | −0 | — | — | — | — |
| EBIT | 2 362 | 2 697 | 3 206 | 5 311 | 4 445 | 25 228 | 11 906 | 11 307 | 6 939 | 8 373 |
| Net financials | −7 | −7 | −2 | −2 | −2 | −4 | 2 | 1 064 | 2 118 | 1 451 |
| Profit before tax | 2 505 | 2 690 | 3 204 | 3 309 | 3 344 | 18 924 | 9 008 | 0 | 10 341 | 0 |
| Tax | −558 | −599 | −713 | −738 | −721 | −4 063 | −1 880 | −0 | −2 280 | −0 |
| Net profit | 1 947 | 2 091 | 2 491 | 2 571 | 2 623 | 14 861 | 7 128 | 0 | 8 061 | 0 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 27 598 | 23 906 | 26 567 | 19 014 | 21 919 | 47 816 | 59 917 | 68 376 | 64 097 | 62 458 |
| Equity | 5 943 | 8 034 | 10 525 | 13 095 | 15 718 | 30 579 | 37 707 | 37 707 | 45 770 | 45 769 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 21 655 | 15 872 | 16 042 | 5 919 | 5 101 | 9 837 | 11 910 | 20 369 | 18 327 | 16 689 |
| Total debt | 21 655 | 15 872 | 16 042 | 5 919 | 5 101 | 9 837 | 11 910 | 20 369 | 18 327 | 16 689 |
EBITDA margin
12.5%
This company
15.8%
Market median
-21% vs market
20162025
Equity ratio
73.3%
This company
38.2%
Market median
+92% vs market
20162025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20162025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20162025
Asset turnover
1.08×
This company
1.12×
Market median
+4% vs market
20162025
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AL External Signatory | External Signatory | 2021 | — | — |
PO Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
LE Chief Auditor | Chief Auditor | 2021 | — | — |
TM Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2022 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Capio Specialistkliniker AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Capio AB (publ)
Capio SkinDoc AB Board members of Capio SkinDoc AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexander Lars Rydholm | External Signatory | 0 companies |
| Per-Håkan Olausson | Chief Executive Officer | 0 companies |
| Linda Elisabeth Sallander | Chief Auditor | 0 companies |
| Terese Mildred Marie Sandberg | Chief Executive Officer | 0 companies |
| Claes Jihmmy Ingvarsson | Board of Directors | 0 companies |
| Kristin Camilla Deibe | Board of Directors | 0 companies |
| Karl Arne Johansson Bäckgren | Board of Directors | 0 companies |
| Malin Victoria Bohlin | Board of Directors | 0 companies |
| Karin Astrid Lindh | Board of Directors | 0 companies |
| Ewa Johanna Danielsen | Board of Directors | 0 companies |